ArticleCancer immunology, immunotherapy : CII2019

PTPN3 expressed in activated T lymphocytes is a candidate for a non-antibody-type immune checkpoint inhibitor.

Akiko Fujimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.